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Abstract
Background: Eclampsia and pre-eclampsia are well-recognized causes of maternal and neonatal mortality in low
income countries, but are never studied in a district hospital. In order to get reliable data to facilitate the hospital’s
obstetric audit a retrospective medical record study was performed in Ndala Hospital, Tanzania.
Methods: All patients diagnosed with severe pre-eclampsia or eclampsia between July 2011 and December 2012
were included. Medical records were searched immediately following discharge or death. General patient characteristics,
medical history, obstetrical history, possible risk factors, information about the current pregnancy, antenatal clinic
attendance and prescribed therapy before admission were recorded. Symptoms and complications were noted.
Statistical analysis was done with Epi Info®.
Results: Of the 3398 women who gave birth in the hospital 26 cases of severe pre-eclampsia and 55 cases of eclampsia
were diagnosed (0.8 and 1.6 %). Six women with eclampsia died (case fatality rate 11 %). Convulsions in patients with
eclampsia were classified as antepartum (44 %), intrapartum (42 %) and postpartum (15 %). Magnesium was given in
100 % of patients with eclampsia and was effective in controlling convulsions. Intravenous antihypertensive treatment
was only started in 5 % of patients. Induction of labour was done in 29 patients (78 % of women who were not yet in
labour). Delivery was spontaneous in 67 %, assisted vaginal (ventouse) in 14 % and by Caesarean section in 19 % of
women. Perinatal deaths occurred in 30 % of women with eclampsia and 27 % of women with severe pre-eclampsia
and were associated with low birth weight and prolonged time between admission and birth.
Conclusions: 2.4 % of women were diagnosed with severe pre-eclampsia or eclampsia. The case fatality rate and overall
perinatal mortality were comparable to other reports. Better outcomes could be achieved by better treatment of
hypertension and starting induction of labour as soon as possible.
Background
Hypertensive disorders in pregnancy affect 10 % of women
and are a main cause of maternal morbidity and mortality
worldwide, accounting for more than 50 % of maternal
deaths in sub-Saharan Africa [1, 2]. In Tanzania the mater-
nal mortality rate is 454/100.000 of which the proportion
caused by hypertensive disorders is unknown [3]. Case
fatality rates (CFR) of eclampsia are reported 1–2 % in
high income countries (HIC) [4, 5]. In low-income coun-
tries (LIC) CFRs vary, but are usually much higher: in two
studies from Tanzanian tertiary centres CFRs of 5–8 %
were reported [6, 7]. In these studies perinatal mortality
was 20–39 % [6, 7].
In the recent decade attention for maternal mortality
due to hypertensive disorders has been growing [8–10].
Audit of maternal morbidity and mortality cases due to
hypertensive disease in pregnancy has been reported in
HIC and LIC [9, 11]. Audit has been introduced at
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national but also at facility level, where it leads to discus-
sion and formulation of feasible local protocols [12–15].
In a district-level hospital in rural Tanzania, maternal
mortality audits are held regularly. Since 2010, the med-
ical and labour room staff discuss all recent maternal
deaths. In 2010, during such a meeting, two deaths in-
volving women with eclampsia who died from complica-
tions following caesarean section (CS) were discussed.
Since only charts of deceased patients were available
for the audit, no comparison was possible with patients
with eclampsia who survived. In order to facilitate the
audit process and to identify more ways to improve care
of these patients, we decided to conduct a medical re-
cords study. This paper describes and analyzes the char-
acteristics, treatment and maternal and foetal outcome
of patients with severe pre-eclampsia and eclampsia
treated in Ndala Hospital in 2011 and 2012, with the
aim to better understand pre-eclampsia and eclampsia in
this setting and to identify ways to improve care.
Methods
This study was done at Ndala Hospital, a private Catholic
hospital, situated in the Tabora region, in a rural part of
Western Tanzania. It serves a catchment area of approxi-
mately 200,000 people. Annually, there are approximately
2200 deliveries in the hospital. Some women plan to give
birth in the hospital, while others come after failing to give
birth at home or in one of the nearby government or
private health centres, up to 50 km from Ndala. There
is a poor referral infrastructure, which means that many
women are self-referrals from home or health centres,
rarely with any written handover. Comprehensive emer-
gency obstetric care (CEmOC) is available and conducted
by three health care workers: one medical officer (medical
degree) and two diploma-level assistant medical officers.
There are virtually no possibilities for urgent referral to
the regional hospital.
Medical records from all patients diagnosed with severe
pre-eclampsia or eclampsia in Ndala Hospital between
July 2011 and December 2012 were analysed. These pa-
tients were identified by the first author (RM) or one of
the attending doctors. Medical records were searched im-
mediately following discharge or death and a standard
case record form was filled in by the discharging doctor
and cross-checked. In case of discrepancies or missing
data, the medical records were checked again. General pa-
tient characteristics, medical history, obstetrical history,
possible risk factors (such as previous history, nulliparity,
co-morbidities), information about the current pregnancy
(gravidity, parity, gestational age (GA)), antenatal clinic
(ANC) attendance and prescribed therapy before admis-
sion were recorded. Also symptoms, including blood pres-
sure (BP), were noted on and during admission. Finally,
severe complications (such as eclampsia or post-partum
haemorrhage) and maternal and foetal survival were
noted. The definitions that were used are given in Table 1.
The hospital protocol categorises hypertension in eclamp-
tic patients in: hypertension, severe hypertension and
hypertensive crisis. If a definite diagnosis could not be
made due to absent data on proteinuria, the diagnosis
made by the clinician was used to determine inclusion
in this study. Detection and estimation of proteinuria
was done with the quantitative test using precipitation of
30 % sulfosalicylic acid [16]. Diagnosis of HELLP syndrome
was not possible in the laboratory, but was suspected in
case of jaundice and signs of a bleeding disorder. Magne-
sium sulphate (MgSO4) was used as anti-convulsive ther-
apy, or could be used to prevent convulsions in patients
diagnosed with severe pre-eclampsia [17]. A bolus of 4 g
intravenously (IV) in 20 min was given. After that, accord-
ing to the hospital protocol, MgSO4 was administered
intravenously 4 g 4-hourly during the first year of the
study. This was changed in 2012 to the same dose ad-
ministered intramuscularly because of easier and safer
administration. Oral antihypertensive drugs were meth-
yldopa, hydralazine or nifedepine [18]. IV antihyperten-
sive treatment was with hydralazine consecutive bolus
injections until the BP was within predefined range (below
160/110 mmHg). Induction of labour was done with miso-
prostol 25 mg vaginally 8–12 hrly. No other methods of
induction were used. Augmentation of (established or
induced) labour with oxytocin could be considered. No
cardiotocography was used.
Table 1 Definitions
Definition Inclusion
criterion?a
Hypertension diastolic BP ≥ 90 mmHg or
systolic BP ≥ 140 mmHg
Severe hypertension diastolic BP ≥ 110 mmHg or
systolic BP ≥ 160 mmHg
Hypertensive crisis diastolic BP ≥ 120 mmHg or
systolic BP ≥ 180 mmHg
Mild pre-eclampsia Proteinuria WITH: No
-Hypertension WITHOUT signs
or symptomsb
Severe pre-eclampsia Proteinuria WITH: Yes
-Hypertension AND signs, OR
-Severe hypertension
Eclampsia Hypertension Yes
Proteinuria
Convulsions
aThe hospital protocol categorises hypertension in hypertension, severe
hypertension and hypertensive crisis. If a definite diagnosis could not be made
due to absent or unreliable data on proteinuria, the diagnosis made by the
clinician was used to determine inclusion in this study
bSigns: oedema, signs of clotting disorder, jaundice. Symptoms: headache,
epigastric pain, nausea
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This retrospective study was performed as part of the
maternal mortality audit quality improvement activities.
All data were written down by the health workers as part
of routine care and after discharge collected anonym-
ously from patient records. Because of the retrospective
nature of the study, informed consent could not be ob-
tained, but the data could not be traced back to an indi-
vidual patient. Written permission and ethical clearance
was obtained from the medical officer in charge as well,
the district medical officer and the directorate of re-
search and publications of the University of Dodoma
(ref. UDOM/DRP/346).
Data management was done locally using Microsoft
Excel®, statistical analysis was done with Epi Info®. P-values
were calculated with χ2 (Yates corrected P-value), Fisher-
Exact test, Mann–Whitney /Wilcoxon or T-test, whether
appropriate.
Results
During the study period 3398 women gave birth in the
hospital. In this period 19 maternal deaths occurred.
Twenty-six cases of severe pre-eclampsia and 55 cases of
eclampsia were diagnosed (0.8 and 1.6 % respectively).
Of all these women essential information could be re-
trieved. There is no method of checking whether all of
the cases occurring in the study period were included.
Every effort was done to include all cases as files were
searched immediately after discharge. It is unlikely many
cases if all have been missed.
Six women with eclampsia died (CFR eclampsia: 11 %,
32 % of all maternal deaths). Table 2 shows baseline
characteristics, risk factors, signs and symptoms on ad-
mission and ANC attendance. Of all patients baseline
characteristics and details about delivery could be re-
trieved. Women had a mean age of 22 years and most of
them reported to be term.
Convulsions in patients with eclampsia were classified
as antepartum (44 %), intrapartum (42 %) and postpartum
(15 %). Convulsions most commonly occurred (30/55,
55 %) after onset of labour or within 24 h after birth. Of
the eight women (15 %) with postpartum convulsions,
seven women (88 %) developed eclampsia within 24 h,
one woman (1 %) had convulsions 1 week after delivery
(late post-partum eclampsia). Of the 15 patients who
developed eclampsia after admission, five (33 %) had nor-
mal blood pressure on admission. Proteinuria was found
in 18 patients (70 %) with pre-eclampsia. In seven patients
with pre-eclampsia urine was not checked and one patient
tested negative for proteinuria. Of the patients with
eclampsia, 37 (67 %) had proteinuria, in 15 patients
(27 %) proteinuria was not checked and in three (5 %)
urine was tested negative for proteinuria.
Anti-convulsive treatment was started with MgSO4 in
all patients with eclampsia. To prevent convulsions in
patients diagnosed with severe pre-eclampsia magne-
sium therapy was given to 22 patients (85 %) (Table 3).
No serious side-effects of MgSO4 were reported. In three
patients who received magnesium treatment for eclamp-
sia (5 %) the magnesium was discontinued for some
time. Another three patients needed a higher dose (1.5 g
per hour) because of continued convulsions when on
standard dose magnesium therapy.
IV antihypertensive treatment was started with hydral-
azine in four patients (5 %). Oral treatment with either
methyldopa, hydralazine or nifedepine was given in 53
patients (65 %). In the group of 31 patients with hyper-
tensive crisis on admission, four (13 %) received an IV
antihypertensive. Twenty-one patients (68 %) used oral
antihypertensives and six (19 %) did not get any antihy-
pertensives. Of the 31 patients with hypertensive crisis,
after 24 h, blood pressure was not effectively treated in
eight patients (26 %), two patients (6 %) had died.
The majority of the included women (44/81, 54 %)
were in labour or already had given birth. In 29 cases
misoprostol was used to induce labour (36 % of all cases,
78 % of women who were not yet in labour). In 27 women
induction resulted in established labour. One woman under-
went CS because of failed induction and one died before
getting contractions. Average time between admission and
delivery in women in whom labour was induced was 68 h;
62 h in patients with eclampsia. Seven women without
contractions on admission established spontaneous labour.
Most women gave birth spontaneously. Assisted vaginal
deliveries (ventouse) were done 11 times (14 %, see Table 3).
CS was done in 15 cases (19 %), most of them (10, 67 %)
because of prolonged or obstructed labour.
Of 81 women, nine (11 %) had twins resulting in 90
foetuses. Eighteen perinatal deaths (30 %) occurred in
women with eclampsia and six (27 %) in women with se-
vere pre-eclampsia (details are shown in Table 4). More
than a third of the neonates of less than 2.5 kg (15/40,
38 %) died, and 6 out of 7 (86 %) of the neonates with a
birth weight of less than 1.5 kg. In women with
eclampsia who developed convulsions after being ad-
mitted almost all (15/16, 93 %) children survived. In
women with post-partum eclampsia neonatal survival
was 100 % (10/10). Of the 26 perinatal deaths (20 fresh
stillbirths and 6 neonatal deaths), 11 (42 %) occurred
before admission, nine (35 %) in utero during admis-
sion and six (23 %) after delivery. There was one foetal
death after induction with misoprostol due to cord
prolapse after spontaneous rupture of membranes. Of
the six children that died between delivery and discharge of
the mother, five (83 %) had a birth weight of less than
2.5 kg (average 1.71 kg). Longer duration between admission
and delivery was associated with poor neonatal survival.
Of six maternal deaths, two occurred ante partum. One
patient with post-partum eclampsia gave birth before
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admission, but died later. There was one death due to
shock after complications of CS (suspected abdominal
bleeding), one due to possible HELLP-syndrome and multi-
organ failure and one due to hypovolaemic shock caused by
post-partum haemorrhage (PPH). Three deaths were of un-
known causes, possible due to embolism, intra-cerebral
haemorrhage; magnesium toxicity could not always be
ruled out. No autopsies were performed. In all maternal
deaths diastolic blood pressure was over 110 mmHg on ad-
mission, and four had hypertensive crisis.
Discussion
This paper describes and analyzes the characteristics, treat-
ment and maternal and foetal outcome of patients with
severe pre-eclampsia and eclampsia treated in Ndala
Hospital in 2011 and 2012, with the aim to better under-
stand pre-eclampsia and eclampsia in this setting and to
identify ways to improve care. We have shown that con-
ducting an observational study concerning pre-eclampsia
within the context of audit is feasible in a rural district
hospital in a LIC. The results of the study have helped
hospital management to better understand what happens
with patients with pre-eclampsia and eclampsia in the dis-
trict and to improve the quality of care for these patients
diagnosed in the hospital.
In our hospital, in contrary to hospitals in HIC, pre-
eclampsia is less common than eclampsia [8]. There
are a few possible explanations. Firstly, there could be
Table 2 Patient characteristics
Pre-eclampsia (n = 26) Eclampsia (n = 55) P-value
Median age (years, interquartile range) 21.5 (19–29) 20 (16–22) 0.01
Mean length of admission (days, standard deviation) 5.2 (3.3) 5.3a (3.7) 0.92
Median self-reported term of pregnancy (months, interquartile range) 9 (8–9) 9 (8–9) 0.82
Nulliparity 10 (39 %) 32 (58 %) 0.16
Presenting signs and symptoms
In labour on admission 14 (54 %) 23 (42 %) 0.44
Not in labour on admission 12 (46 %) 25 (46 %) 0.86
Delivered on admission 0 7 (13 %) 0.09
Severe hypertension or crisis 22 (85 %) 31 (56 %) 0.01
Proteinuria 18 (69 %) 37 (67 %) 0.94
Headache 7 (27 %) 28 (51 %) 0.07
Visual problems 1 (3.8 %) 8 (15 %) 0.26
Signs of clotting disorder 1 (3.8 %) 7 (13 %) 0.43
Jaundice 0 3 (5.5 %) 0.55
Oedema 16 (62 %) 23 (42 %) 0.16
Hyperreflexia 8 (31 %) 25 (45 %) 0.31
Risk factors:
Previous pregnancy with pregnancy induced hypertension (with or without eclampsia) 2 (7.7 %) 4 (7.3 %) 1.00
Multiple gestation 4 (15 %) 5 (9.1 %) 0.46
First or new husband 19 (73 %) 38 (69 %) 0.92
None of the above risk factors 3 (12 %) 12 (22 %) 0.36
Co morbidities:
HIV 0 1 (1.8 %) 1.00
Anaemia 1 (3.8 %) 1 (1.8 %) 0.54
Antenatal clinic visits:
Number of women with ANC records 23 (88 %) 52 (95 %) 0.38
Of which BP or urine was checked 22 (96 %) 33 (63 %) 0.01
Median number of visits of the patients who went at least once (interquartile range) 3 (2–5) 3 (2–5) 0.42
At least 4 visits to ANC 9 (35 %) 14 (25 %) 0.56
BP checked <14 days before admission 10 (38 %) 8 (15 %) 0.03
BP diastolic <90 mmHg not more than 2 weeks ago 7 (27 %) 5 (9 %) 0.08
aOf the patients discharged alive (n = 49)
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selection bias. Patients with pre-eclampsia often give
birth at home unnoticed and do not seek help until
they get convulsions. Another explanation could be un-
derdiagnosis of pre-eclampsia due to poor quality of BP
measurements during ANC visits. The clinical picture of
pre-eclampsia is heterogeneous with some women pro-
gressing fast to hypertensive crisis and convulsions, while
others have an insidious rise in BP and impaired foetal
growth. A third of the patients who developed eclampsia
after admission had normal blood pressure measurement
at the moment of admission and in five of eight women
(63 %) with eclampsia who had their BP checked less than
2 weeks before admission no hypertension was recorded.
The observed proportion of women with eclampsia get-
ting convulsions after giving birth (15 %) is comparable
with other LIC, but less than in HIC [4, 5, 7], probably
due to many deliveries not being attended by skilled
health care workers.
Since the inclusion was based on clinical diagnosis,
some patients were included with the diagnosis of pre-
eclampsia or eclampsia, while urine was not checked for
proteinuria or proteinuria was absent (32 % of the cases).
The method we used for diagnosing proteinuria using
30 % sulfosalicylic acid precipitation is not reliable [19],
and no longer recommended [20]. Since reliable urine
measurements are often not available in hospitals in LIC,
our study reflects the common practice of diagnosing
pre-eclampsia and eclampsia in such small rural hospitals.
Although definitions exist to diagnose pre-eclampsia
without proteinuria [21, 22], other diagnostic criteria are
equally difficult to find in a rural setting.
Prevention of eclampsia by (early) identification and
treatment of pre-eclampsia is difficult. Many women do
not have obvious risk factors (only 7.4 % had a history of
PIH). Signs and symptoms can be absent or present
shortly: for example, 12 of 18 patients (67 %) had a nor-
mal BP within 2 weeks before admission. Increasing the
number of ANC visits and BP measurements will improve
detection of hypertensive disorders in pregnancy, but is
a challenge in Tanzania. Small ANC clinics are often
short of sphygmomanometers [23] and in rural Tanzania,
though most women attend ANC regularly, many choose
to give birth at home [3, 24–26]. Another problem in early
detection and prevention is late booking [27]. We found a
high ANC attendance of more than 90 %, but only 23
women (28 %) attended the recommended four visits [28].
In our study, in 55 % of women eclampsia occurred after
onset of labour or within 24 h after birth. This means that
increasing the number of hospital deliveries and ensuring
Table 3 Treatment
Pre-eclampsia (n = 26) Eclampsia (n = 55) P-value
Magnesium treatment 22 (85 %) 55 (100 %) 0.01
Of which with loading dose 18 (82 %) 50 (91 %) 0.27
Magnesium dose raised because continued convulsions 0 (0 %) 3 (5 %) 0.55
Median time of magnesium treatment (hours, interquartile range) 30 (24–38) 32 (25–50) 0.16
Antihypertensive treatment 22 (85 %) 35 (64 %) 0.07
Delivery
Spontaneous delivery 20 (77 %) 33 (60 %) 0.21
Assisted vaginal delivery 1 (4 %) 10 (18 %) 0.09
CS 5 (19 %) 10 (18 %) 0.85
Died before delivery 0 2 (4 %) 1.00
Delivery during admission (number) 26 (100 %) 46 (84 %) 0.05
Mean time after admission (hours, standard deviation) 45 (58) 38 (58) 0.67
Women not in labour, not yet delivered 12 (46 %) 25 (45 %) 1.00
Induction misoprostol 10 (83 %) 19 (67 %) 1.00
Spontaneous in labour 2 (17 %) 5 (20 %) 1.00
Primary CS 0 (0 %) 1 (4 %) 0.70
Table 4 Foetal outcomes (90 foetuses)
Pre-eclampsia
(n = 30)
Eclampsia
(n = 60)
P-value
Alive on birth 24 (80 %) 46 (77 %) 0.93
Alive at moment of discharge 22 (73 %) 42 (70 %) 0.93
Alive at moment of discharge
with mother alive
22 (73 %) 39 (65 %) 0.58
Mean birth weight (kg, standard
deviation)
2.6 (0.80) 2.3 (0.69)a 0.12
Birth weight <2.5 kg 11 (37 %) 29 (49 %)a 0.37
Birth weight <1.5 kg 2 (7 %) 5 (8 %)a 0.91
a Birth weight was available for 59 children
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qualified hospital staff can help to early recognize and
treat pre-eclampsia and eclampsia.
Magnesium therapy was available during the study
period and used in all patients with eclampsia and most
patients with pre-eclampsia. Although severe hypertension
and hypertensive crisis were common, IV antihypertensive
treatment was often not installed, against the recommen-
dations of the hospital protocol. Suboptimal BP manage-
ment has been identified as a possible cause for morbidity
in European countries as well [29]. The high number of
women with persistent severe hypertension 24 h after ad-
mission highlights the importance of better monitoring of
the patients and, if necessary, earlier and more aggressive
treatment [30]. Another factor in underuse of IV antihy-
pertensives is the unreliable stock of hydralazine in the
hospital.
In 29 patients labour was induced; only one (3,4 %)
needed CS because of failed induction. This is comparable
to the observed success rate of Kidanto et al. [31]. The
time between induction and delivery was not documented
and some women started induction some time after ad-
mission, due to delayed diagnosis, delay in starting induc-
tion or because of waiting to finish steroid treatment.
More emphasis needs to be put on starting induction as
soon as possible after stabilisation. Our data show that al-
most all women will gave birth vaginally after induction.
CS should be discouraged, since it poses women with se-
vere pre-eclampsia and eclampsia under increased risk for
morbidity and even mortality [32].
Use of ventouse deliveries reduced the number of CS
without any complications recorded. The use of assisted
vaginal deliveries is not part of standard medical practice
in Tanzania [33, 34], although in tertiary centres it is used
successfully [6, 7]. Ventouse deliveries are part of the Basic
Emergency Obstetric Care (BEmOC) package of services,
an effective strategy propagated by the WHO to address
the most common direct obstetric complications [35, 36].
Performing assisted vaginal deliveries on right indications,
in order to prevent (emergency) CS and its short- and
long-term complications, should be a priority [37, 38].
The perinatal mortality of 30 % in eclampsia is similar to
other reports. Perinatal mortality related to pre-eclampsia,
27 % in our group, is rarely studied in Africa. Since GA
could not be obtained reliably, it was impossible to dis-
tinguish prematurity and small for GA. Lower GA and
lower birth weight were predictors for foetal and neonatal
death. Children of women with convulsions starting dur-
ing admission with prompt treatment had better chances
to survive.
Data from this retrospective study were collected from
patient records shortly after discharge (or death), which
ensures more complete and more accurate data collection
than a retrospective study longer after discharge could.
There are several limitations as well. Data collection was
not blinded and could be subject to information bias. Some
variables and outcomes are based on clinical judgement of
attending doctors and not blinded for end points. Also se-
lection bias of patients with pre-eclampsia not being identi-
fied can be suspected. These limitations are a reality in
auditing pre-eclampsia and eclampsia in a small hospital.
However, very few studies are conducted in district-
level facilities in LIC, while they constitute a large propor-
tion of all health facilities and the first point of care for
many patients. For that reason the authors believe that the
findings from this study can be of importance for health
workers working in similar conditions. Further studies
should focus on evaluating the optimal management strat-
egy for patients with pre-eclampsia and eclampsia in rural
settings in LIC. Prospective studies can identify the best
strategy of delivery, including timing of CS.
Conclusion
The CFR of eclampsia was 11 % and the perinatal mortal-
ity 30 % in this rural hospital. Longer admission to deliv-
ery intervals were not associated with maternal mortality.
Foetal death is associated with low birth weight and
prolonged time between admission and birth. Better
outcomes could be achieved by better treatment of hyper-
tension and starting induction of labour as soon as possible
(after stabilising the condition of the mother). Reliable pro-
tein measurements should be available for accurate diagno-
sis. Most women gave birth vaginally after induction of
labour with misoprostol. This practice of first stabilising
maternal condition and then opting for a vaginal birth
has proven to be safe, even in those who eventually
needed a CS.
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